Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VKA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02607371
What this trial is testing

Anticoagulation Preference by AF Patients Study

Who this might be right for
Atrial Fibrillation
Bayer 198
Not applicableUnknownNCT02706080
What this trial is testing

Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

Who this might be right for
Antithrombotic Agents
University Hospital, Clermont-Ferrand 10
Not applicableStudy completedNCT02690155
What this trial is testing

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

Who this might be right for
Atrial Fibrillation
Bayer 38,831
Not applicableStudy completedNCT02611635
What this trial is testing

Atrial Fibrillation Patient Preference Study

Who this might be right for
Atrial Fibrillation
Bayer 382
Not applicableStudy completedNCT01029743
What this trial is testing

Xarelto Regulatory Post-Marketing Surveillance

Who this might be right for
Venous Thromboembolism
Bayer 3,388
Not applicableStudy completedNCT01362933
What this trial is testing

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Who this might be right for
NeoplasmsVenous Thromboembolism
Floralis 502
Not applicableStudy completedNCT02319460
What this trial is testing

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Who this might be right for
Hemorrhage
CSL Behring 2,238
Not applicableStudy completedNCT02960334
What this trial is testing

Screening for Actionable Atrial Fibrillation During Preoperative Consultation With the MyDiagnostick

Who this might be right for
Atrial Fibrillation
Martini Hospital Groningen 505
Post-approval studies (Phase 4)Study completedNCT03064035
What this trial is testing

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

Who this might be right for
Acute Bleeding on Long-Term Anticoagulation TherapyHemorrhageSignificant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)+1 more
HealthPartners Institute 79
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableStudy completedNCT03093233
What this trial is testing

Multicenter Analysis of Oral Anticoagulant-associated ICH - Part Two

Who this might be right for
Anticoagulation Associated (VKA & NOAC) Intracerebral Hemorrhage
University of Erlangen-Nürnberg Medical School 1,369
Not applicableStudy completedNCT04518735
What this trial is testing

Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)

Who this might be right for
Covid19
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,707
Large-scale testing (Phase 3)Study completedNCT02664649
What this trial is testing

Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis

Who this might be right for
Symptomatic Aortic StenosisEligible for Transcatheter Aortic Valve Replacement
Assistance Publique - Hôpitaux de Paris 1,510
Large-scale testing (Phase 3)Ended earlyNCT02618577
What this trial is testing

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Who this might be right for
Atrial High Rate Episodes
Atrial Fibrillation Network 2,608
Testing effectiveness (Phase 2)WithdrawnNCT04002011
What this trial is testing

DOAC Versus VKA After Cardiac Surgery

Who this might be right for
Anticoagulant-induced Bleeding
Laval University
Not applicableEnded earlyNCT03715725
What this trial is testing

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.

Who this might be right for
Non-valvular Atrial Fibrillation
Bayer 70,000
Very early researchNot Yet RecruitingNCT07011095
What this trial is testing

DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

Who this might be right for
Atrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation)
Population Health Research Institute 100
Not applicableStudy completedNCT04117048
What this trial is testing

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

Who this might be right for
Vitamine K Antagonist (VKA) TreatmentInternational Normalized Ratio (INR) Measure at HomeThromboembolic Pathology
Medicalps 128
Large-scale testing (Phase 3)UnknownNCT06143787
What this trial is testing

Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction

Who this might be right for
Bleeding From TeethBleeding Prophylaxis
Hyloris Developments 280
Next Page